Details of the Drug Inactive Ingredient (DIG)
General Information of DIG (ID: E0D4QT) | |||||
---|---|---|---|---|---|
DIG Name |
Polyethylene glycol 1000
|
||||
DIG Function |
Coating agent; Diluent; Ointment base; Plasticizing agent; Solvent; Suppository base; lubricant
|
||||
Full List of Active Pharmaceutical Ingredients (APIs) Co-administrated with This DIG | ||||||
---|---|---|---|---|---|---|
ICD Disease Classification 01 | Infectious/parasitic disease | Click to Show/Hide | ||||
Linezolid
|
API Info |
Streptococcus bacterial infection [ICD-11: 1C41]
|
[1] | |||
ICD Disease Classification 02 | Benign/in-situ/malignant neoplasm | Click to Show/Hide | ||||
Nicotinic acid
|
API Info |
Lung cancer [ICD-11: 2C25]
|
[2] | |||
Capecitabine
|
API Info |
Colon cancer [ICD-11: 2B90]
|
[3] | |||
ICD Disease Classification 04 | Immune system disease | Click to Show/Hide | ||||
Cetirizine
|
API Info |
Allergy [ICD-11: 4A80]
|
[4] | |||
ICD Disease Classification 05 | Endocrine/nutritional/metabolic disease | Click to Show/Hide | ||||
Fenofibrate
|
API Info |
Hypertriglyceridaemia [ICD-11: 5C80]
|
[5] | |||
Potassium chloride
|
API Info |
Hypokalemia [ICD-11: 5C77]
|
[6] | |||
ICD Disease Classification 06 | Mental/behavioural/neurodevelopmental disorder | Click to Show/Hide | ||||
Bupropion
|
API Info |
Nicotine dependence [ICD-11: 6C4A]
|
[7] | |||
Venlafaxine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[8] | |||
Olanzapine
|
API Info |
Schizophrenia [ICD-11: 6A20]
|
[9] | |||
Cyclobenzaprine
|
API Info |
Major depressive disorder [ICD-11: 6A70]
|
[10] | |||
ICD Disease Classification 07 | Sleep-wake disorder | Click to Show/Hide | ||||
Zolpidem
|
API Info |
Insomnia [ICD-11: 7A00]
|
[11] | |||
ICD Disease Classification 08 | Nervous system disease | Click to Show/Hide | ||||
Acetaminophen
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[12] | |||
Tramadol
|
API Info |
Anaesthesia [ICD-11: 8E22]
|
[13] | |||
Topiramate
|
API Info |
Focal seizure [ICD-11: 8A68]
|
[14] | |||
Zolmitriptan
|
API Info |
Migraine [ICD-11: 8A80]
|
[15] | |||
ICD Disease Classification 10 | Ear/mastoid process disease | Click to Show/Hide | ||||
Diphenhydramine
|
API Info |
Meniere disease [ICD-11: AB31]
|
[16] | |||
ICD Disease Classification 11 | Circulatory system disease | Click to Show/Hide | ||||
Aspirin
|
API Info |
Myocardial infarction [ICD-11: BA41]
|
[17] | |||
Caffeine
|
API Info |
Orthostatic hypotension [ICD-11: BA21]
|
[18] | |||
ICD Disease Classification 15 | Musculoskeletal/connective-tissue disease | Click to Show/Hide | ||||
Naproxen
|
API Info |
Rheumatoid arthritis [ICD-11: FA20]
|
[19] | |||
ICD Disease Classification 16 | Genitourinary system disease | Click to Show/Hide | ||||
Ibuprofen
|
API Info |
Dysmenorrhea [ICD-11: GA34]
|
[20] | |||
Phenazopyridine
|
API Info |
Infectious cystitis [ICD-11: GC00]
|
[21] | |||
Full List of Biological Targets of DIG (DBTs) Regulated by This DIG | ||||||
---|---|---|---|---|---|---|
Oxidoreductase (ORase) | ||||||
DBT Name: Albendazole monooxygenase (CYP3A4) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | Inhibition ratio < 60 % (tested by experiment) | [22] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A4_HUMAN | |||||
DBT Name: Cytochrome P450 2E1 (CYP2E1) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 75.3 uM (tested by experiment) | [23] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2E1_HUMAN | |||||
DBT Name: Cytochrome P450 2C9 (CYP2C9) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 365.6 uM (tested by experiment) | [23] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2C9_HUMAN | |||||
DBT Name: Mephenytoin 4-hydroxylase (CYP2C19) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 139 uM (tested by experiment) | [23] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2CJ_HUMAN | |||||
DBT Name: Debrisoquine 4-hydroxylase (CYP2D6) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 409.6 uM (tested by experiment) | [23] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP2D6_HUMAN | |||||
DBT Name: Cytochrome P450 3A5 (CYP3A5) | Click to Show/Hide | |||||
Detailed Information | DBT Info click to show the detail info of this DBT | |||||
Experiment for Assessing the Biological Activity of the Studied DIG on This DBT | ||||||
Biological Activity | IC50 = 78 uM (tested by experiment) | [23] | ||||
Tested Species | Homo sapiens (Human) | |||||
UniProt ID | CP3A5_HUMAN | |||||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.